0001662244-18-000001.txt : 20180328 0001662244-18-000001.hdr.sgml : 20180328 20180328165142 ACCESSION NUMBER: 0001662244-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180328 DATE AS OF CHANGE: 20180328 EFFECTIVENESS DATE: 20180328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cyteir Therapeutics, Inc. CENTRAL INDEX KEY: 0001662244 IRS NUMBER: 455429901 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-308831 FILM NUMBER: 18719463 BUSINESS ADDRESS: STREET 1: 763E CONCORD AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 617-248-5239 MAIL ADDRESS: STREET 1: 763E CONCORD AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02138 D 1 primary_doc.xml X0708 D LIVE 0001662244 Cyteir Therapeutics, Inc. 763E CONCORD AVENUE CAMBRIDGE MA MASSACHUSETTS 02138 617-248-5239 DELAWARE None None Corporation true Ronald Goldstein c/o Cyteir Therapeutics, Inc. 763E Concord Avenue Cambridge MA MASSACHUSETTS 02138 Executive Officer Timothy Romberger c/o Cyteir Therapeutics, Inc. 763E Concord Avenue Cambridge MA MASSACHUSETTS 02138 Executive Officer Director Markus Renschler c/o Cyteir Therapeutics, Inc. 763E Concord Avenue Cambridge MA MASSACHUSETTS 02138 Executive Officer Director Racquel Bracken c/o Cyteir Therapeutics, Inc. 763E Concord Avenue Cambridge MA MASSACHUSETTS 02138 Director Bart Van Hooland c/o Cyteir Therapeutics, Inc. 763E Concord Avenue Cambridge MA MASSACHUSETTS 02138 Director Jean George c/o Cyteir Therapeutics, Inc. 763E Concord Avenue Cambridge MA MASSACHUSETTS 02138 Director Other Health Care Decline to Disclose 06b false 2018-01-03 false true false 0 MTS Securities, LLC 104059 None None 623 Fifth Avenue, 14th Floor New York NY NEW YORK 10022 NY NEW YORK CA CALIFORNIA false 29000000 4817829 24182171 false 11 1000000 true 0 Subject to future issuances. 0 false Cyteir Therapeutics, Inc. /s/ Markus Renschler Markus Renschler President and CEO 2018-03-28